ClinicalTrials.govpublic full text
Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease
hyperuricemia, gout, chronic kidney diseases, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 879862
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.